Amarin Corp

NASDAQ: AMRN
$0.86
-$0.01 (-1.4%)
Closing price April 19, 2024
Amarin Corp is a Dublin-based pharmaceutical company focused on creating treatments for cardiovascular diseases. Its flagship product, VASCEPA, is an omega-3 fatty acid prescription used to lower triglyceride levels in adults with severe hypertriglyceridemia, contributing to heart health. Amarin markets its products mainly through wholesalers and specialty pharmacies, also collaborating with Mochida Pharmaceutical for further development. Originally named Ethical Holdings, Amarin has been advancing heart disease treatment since its inception in 1989.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amarin, Apple, AutoNation, BlackRock, E*Trade, Etsy, Kellogg and PG&E.
Amarin shares absolutely skyrocketed on Monday after the company announced topline results from the Vascepa cardiovascular (CV) outcomes trial, REDUCE-IT. Needless to say, the results were very...
Helios and Matheson, Tyson Foods, Amarin, and Western Digital all posted new 52-week lows Monday.
The top analyst upgrades, downgrades and other research calls from Thursday include Amarin, American Express, Barrick Gold, Cameco, Groupon, ImmunoGen, JPMorgan and Whole Foods Market.
Here are 10 analyst picks from the week of October 21 trading under $10 with massive upside calls, including Groupon and MGIC Investment.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include DuPont, GoDaddy, Intel, Pandora Media, Wells Fargo and Western Refining.
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.
Biotech is the one arena that still offers massive upside for investors — if they can pick the right companies that is. They could one day cure cancer, heart issues, diabetes and just about every...
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Baidu, Boeing, Coeur Mining, Flextronics, NXP Semiconductors, Walt Disney and WebMD.
Amarin made some headway in Wednesday's regular trading session following a settlement with the U.S. Food and Drug Administration.
This past week was a break from the endless, six-year bull market. Still, the market remains effectively at all-time highs.
Thursday's top analyst upgrades and downgrades include Amarin, CONSOL Energy, Garmin, GNC, Hewlett-Packard, Peabody Energy and Windstream.
Wednesday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Amarin, CenturyLink, Legg Mason, Rackspace, Transocean and Valero Energy.
These are the top Wall Street analyst upgrades, downgrades and initiations for Monday, May 12, 2014. They include Amarin, Boeing, Cisco, KKR, NetApp and Twitter.
St. Patrick's Day may have come and gone for this year, but the analysts at biotech boutique shop Leerink have highlighted six Ireland-based firms that could be tempting takeover targets for large...